阿哌沙班用于初次全髋和全膝关节置换术后静脉血栓栓塞预防的安全性与有效性
该回顾性队列研究纳入17个月内接受初次全髋或全膝关节置换术后使用阿哌沙班进行血栓预防的230例患者(110例TKA,120例THA),主要适应证为高VTE风险、既往使用阿哌沙班或阿司匹林禁忌。结果显示VTE发生率低(1例TKA患者发生DVT伴PE,0.43%),伤口并发症需手术处理者占2.6%,THA翻修率0.87%。结论认为阿哌沙班在这些特定人群中预防VTE安全有效,血栓和出血并发症风险低。
要点
- 阿哌沙班用于THA/TKA术后VTE预防的VTE发生率低,仅0.43%患者发生DVT伴PE。
- 伤口并发症需手术处理者占2.6%,THA翻修率0.87%,出血并发症风险较低。
- 适用人群包括高VTE风险、既往使用阿哌沙班或阿司匹林禁忌的患者。
核心结论
- 在高VTE风险、既往使用阿哌沙班或阿司匹林禁忌的初次THA/TKA患者中,阿哌沙班用于术后VTE预防与低VTE和出血并发症风险相关。
研究设计与样本
- 回顾性队列研究,纳入17个月内接受初次THA或TKA并术后服用阿哌沙班进行血栓预防的患者,共230例(TKA 110例,THA 120例)。
主要发现
- 1例(0.43%)TKA患者发生DVT伴PE。
- 2.6%的患者发生需手术处理的伤口并发症。
- 0.87%的THA患者接受了翻修关节置换术。
- 高VTE风险状态的主要原因包括个人及家族VTE史,13%的患者术前因心房颤动服用阿哌沙班。
临床怎么用
- 对于初次THA/TKA术后存在高VTE风险、既往使用阿哌沙班或阿司匹林禁忌的患者,可考虑使用阿哌沙班进行VTE预防。
局限性
- 本研究为回顾性队列研究,样本量有限(230例),可能存在选择偏倚和信息偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Venous thromboembolism (VTE) is a serious complication of total hip arthroplasty (THA) and total knee arthroplasty (TKA). Apixaban is approved for VTE prophylaxis. This study seeks to ascertain the risk of VTE and bleeding complications in patients undergoing primary THA and TKA receiving apixaban for postoperative VTE prophylaxis for one of the following indications: high risk for VTE, previously on apixaban, and contraindication to the use of aspirin. METHODS: This is a retrospective cohort study of patients who underwent primary THA or TKA over a 17-month period and were prescribed apixaban for thromboprophylaxis postoperatively. RESULTS: 230 patients were included in the study, 110 TKA and 120 THA. The primary reasons for high-risk VTE status included personal and family history of VTE, and 13% were taking apixaban preoperatively for atrial fibrillation. 1 patient (0.43%) who underwent TKA had a DVT with PE. 2.6% of patients had wound complications requiring operative treatment, and 0.87% of THA patients underwent revision arthroplasty. CONCLUSION: The use of apixaban for VTE prophylaxis after primary THA and TKA in patients at high risk for VTE, in patients previously on apixaban, and in patients with a contraindication to the use of aspirin is associated with a low risk of VTE and bleeding complications.
引用
- Rooney T, Barrack RL, Clohisy JC, et al. Is Apixaban Safe and Effective for Venous Thromboembolism Prophylaxis After Primary Total Hip and Total Knee Arthroplasties? J Arthroplasty. 2021. PMID: 33888386. doi:10.1016/j.arth.2021.03.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。